Free preview

Acute Transplant Rejection

Overview and clinical definition are open. Full Step 1 details unlock with a plan.

For the why behind the fact

Use this page to connect what you are memorizing.

Start with the overview when a class slide, Anki card, or qbank explanation feels too thin. Then use presentation and workup to recognize the condition, and differentials to separate look-alikes.

Overview


Plain-Language Overview

Acute transplant rejection occurs when the recipient’s immune system attacks a donated organ. T cells, antibodies, or both can injure the graft. It can happen early or long after transplantation and may first appear as abnormal monitoring tests without symptoms. Possible symptoms depend on the organ, such as reduced urine output or breathlessness. The transplant team uses organ-specific testing, often including biopsy, to distinguish rejection from infection and other causes of graft dysfunction. Treatment depends on the type and severity; timely treatment can preserve graft function, but severe or persistent rejection may cause graft loss.

Clinical Definition

Acute transplant rejection is active alloimmune injury caused by recipient T cells (TCMR), donor-directed antibodies (AMR), or both. For Step 1, cellular rejection illustrates type IV hypersensitivity, while antibody-mediated endothelial injury illustrates type II hypersensitivity. Kidney TCMR often shows interstitial inflammation, tubulitis and/or arteritis; AMR often involves the microvasculature. Acute rejection can occur months or years after transplantation, including after reduced immunosuppressive exposure. Contrast hyperacute rejection from preformed antibodies, typically within minutes to hours, with chronic rejection, in which persistent immune injury produces structural remodeling and scarring. Timing alone does not establish the subtype.

Clinical Presentation


Diagnostic Workup


Pathophysiology


Treatments


Prevention


Outcome & Complications


Differential Diagnoses